ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 34 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $540,000 | +757.1% | 442,964 | +957.7% | 0.02% | +650.0% |
| Q1 2017 | $63,000 | +425.0% | 41,880 | +209.4% | 0.00% | – |
| Q4 2016 | $12,000 | -91.7% | 13,535 | -87.4% | 0.00% | -100.0% |
| Q3 2016 | $145,000 | +184.3% | 107,233 | +321.9% | 0.00% | +200.0% |
| Q1 2016 | $51,000 | -45.2% | 25,414 | -51.9% | 0.00% | -50.0% |
| Q3 2015 | $93,000 | -14.7% | 52,783 | +28.5% | 0.00% | 0.0% |
| Q2 2015 | $109,000 | +39.7% | 41,091 | +29.4% | 0.00% | 0.0% |
| Q1 2015 | $78,000 | -85.0% | 31,765 | -64.0% | 0.00% | -77.8% |
| Q4 2014 | $520,000 | +632.4% | 88,214 | +727.8% | 0.01% | +800.0% |
| Q3 2014 | $71,000 | – | 10,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 90,000 | $222,000 | 0.17% |
| EQUITEC SPECIALISTS, LLC | 21,820 | $54,000 | 0.02% |
| TFS CAPITAL LLC | 46,886 | $116,000 | 0.01% |
| Westend Capital Management, LLC | 1,000 | $3,000 | 0.00% |
| A.R.T. Advisors, LLC | 33,414 | $82,000 | 0.00% |
| Virtu KCG Holdings LLC | 31,765 | $78,000 | 0.00% |
| RHUMBLINE ADVISERS | 14,080 | $35,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,115 | $2,754,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,489 | $374,000 | 0.00% |
| BlackRock Investment Management, LLC | 73,717 | $182,000 | 0.00% |